# OZURDEX
> **NDA022315** · New Drug Application · Sponsor: ABBVIE · Approved 2009-06-17
## Drug
- **FDA Application Number:** NDA022315
- **Application type:** New Drug Application
- **Brand name:** OZURDEX
- **Generic name:** DEXAMETHASONE
- **Active ingredients:** DEXAMETHASONE
- **Dosage form:** IMPLANT
- **Route:** INTRAVITREAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2009-06-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022315)
---
*MORVS · CC0 1.0*